Phase II, Single Arm, Open Label, Single Center Study of Obinutuzumab and Ibrutinib in the Front Line Treatment of Indolent B-Cell Non-Hodgkin Lymphomas von Kendsersky, Nicholas, Masel, Rebecca, Bhasin, Amman, Zhan, Tingting, Gung, Carol, George, Mercy, Fellin, Frederick Michael, Zibelli, Allison, Bhatia, Avnish, Singla, Rajan, Ramirez, Michael, Chapman, Andrew E., Mille, Patrick, Thomas, Cassandra, Filicko-O'Hara, Joanne, Pro, Barbara, Alpdogan, Onder, Binder, Adam F., Porcu, Pierluigi, Ferber, Andres, Gaballa, Sameh, Martinez Outschoorn, Ubaldo

Volltext